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Dodecylphosphocholine micellesThe human multidrug resistance-associated protein 1 (hMRP1/ABCC1) belongs to the ATP-binding cassette
transporter superfamily. Together with P-glycoprotein (ABCB1) and the breast cancer resistance protein
(BCRP/ABCG2), hMRP1 confers resistance to a large number of structurally diverse drugs. The current
topological model of hMRP1 includes two cytosolic nucleotide-binding domains and 17 putative
transmembrane (TM) helices forming three membrane-spanning domains. Mutagenesis and labeling studies
have shown TM16 and TM17 to be important for function. We characterized the insertion of the TM16
fragment into dodecylphosphocholine (DPC) or n-dodecyl-β-D-maltoside (DM) micelles as membrane
mimics and extended our previous work on TM17 (Vincent et al., 2007, Biochim. Biophys. Acta 1768, 538).
We synthesized TM16 and TM17, with the Trp residues, W1198 in TM16 and W1246 in TM17, acting as an
intrinsic ﬂuorescent probe, and TM16 and TM17 Trp variants, to probe different positions in the peptide
sequence. We assessed the interaction of peptides with membrane mimics by evaluating the increase in
ﬂuorescence intensity resulting from such interactions. In all micelle-bound peptides, the tryptophan residue
appeared to be located, on average, in the head group micelle region, as shown by its ﬂuorescence spectrum.
Each tryptophan residue was partially accessible to both acrylamide and the brominated acyl chains of two
DM analogs, as shown by ﬂuorescence quenching. Tryptophan ﬂuorescence lifetimes were found to depend
on the position of the tryptophan residue in the various peptides, probably reﬂecting differences in local
structures. Far UV CD spectra showed that TM16 contained signiﬁcant β-strand structures. Together with the
high Trp correlation times, the presence of these structures suggests that TM16 self-association may occur at
the interface. In conclusion, this experimental study suggests an interfacial location for both TM16 and TM17
in membrane mimics. In terms of overall hMRP1 structure, the experimentally demonstrated amphipathic
properties of these TM are consistent with a role in the lining of an at least partly hydrophilic transport pore,
as suggested by the currently accepted structural model, the ﬁnal structure being modiﬁed by interaction
with other TM helices.
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The human ATP-binding cassette (ABC) transporter family consists
of 48 integral membrane proteins that are involved in a variety of
physiological processes based on the translocation of speciﬁc
allocrites (transported compounds) across intracellular membranes
or out of the cell [1]. The energy required to transport the allocrite
across a membrane and against a concentration gradient is derived
from the hydrolysis of ATP. Identiﬁed mutations in several ABC
transporters are responsible of genetic diseases (cystic ﬁbrosis,
Tangier disease, Stargardt disease, etc.) [2]. According to phylogenetic
analysis, the 48 ABC transporters are classiﬁed into seven distinct
subfamilies of proteins named ABCA through ABCG [3]. The human
multidrug resistance-associated protein 1 (hMRP1/ABCC1) was
discovered in 1992 and cloned from amultidrug-resistant lung cancer
cell line [4]. The hMRP1 represents the founding member of the ABCC
subfamily which comprises 13 members (http://nutrigene.4t.com/
humanabc.htm). It is expressed constitutively at moderate levels in
most healthy tissues and is capable to transport a wide range of
structurally unrelated molecules including amphiphilic anionic con-
jugates, such as glutathione (GSH)-, glucuronate-, and sulfate-
conjugated aliphatic or heterocyclic compounds, across membranes
[5–7]. hMRP1 also transports unconjugated drugs in the presence of
GSH, likely through a cotransport mechanism [7–12]. Together with
Pgp (ABCB1) [13] and the breast cancer resistance protein, BCRP
(ABCG2/MXR) [14], hMRP1 is associated with the multidrug
resistance phenotype (MDR) [15–17]. The hMRP1 is highly expressed
in many drug-resistant solid tumors like in lung, breast, and prostate
cancers and most probably represents a major obstacle to successful
chemotherapy in lung cancer [6]. Moreover, the fact that substances of
toxicological relevance are transported by hMRP1 together with its
constitutive expression in biological barriers like the blood–brain
barrier suggests it might play a role in defence against xenobiotics.
hMRP1 is a large glycosylated integral membrane protein with an
Mr of 190,000 (1531 residues). According to protein folding
algorithms, it contains three membrane-spanning domains (MSD).Scheme 1. Topology of hMRP1 membrane transporter. (A) Functional unit of hMRP1 conta
(NBD). (B) Isolated sequences of the putative transmembrane TM16 and TM17 fragments wThe current topological model (Scheme 1), which is supported by
epitope insertion [18,19] and glycosylation site mutation data [20],
includes a speciﬁc N-terminal domain, MSD0, preceded by an
extracytosolic N-terminus and followed by a cytosolic loop (L0),
together with two membrane domains MSD1 and MSD2, each
followed by a nucleotide-binding domain (NBD). Five transmembrane
(TM) helices are predicted for MSD0, whereas MSD1 and MSD2 each
consist of six TM fragments. With the exception of MSD0, this
topology is that generally shared by other human ABC full transpor-
ters [21].
High-resolution crystal structures have recently been determined
for ABC transporters from four microorganisms [22]. Two of these
transporters were exporters, like hMRP1: the bacterial lipid trans-
porter MsBA (the published structure of which has since been
retracted [23]) and the Sav1866 transporter from Staphylococcus
aureus, crystallized in two conformations [24,25]. Models of hMRP1
MSD1 and MSD2 have been proposed on the basis of these structures
[5,26,27]. However, the transmembrane segments of these proteins
differ much more than their nucleotide-binding domains, due to
differences in substrate speciﬁcity, so complementary structural
approaches are still informative in the absence of a crystal structure
for hMRP1.
Investigation of the structural properties of membrane proteins
through studies of isolated transmembrane fragments is a widely
recognized approach (e.g., [28,29]). It is based on a two-stage model
[30,31], partly arising from bacteriorhodopsin refolding studies [32],
and suggesting that the folding of membrane proteins includes an
initial step during which independently stable transmembrane
helices are formed and further associate within the membrane. A
more comprehensive view includes additional stages, such as helix–
helix association, leading to further folding events [33]. Initial
events, such as the interfacial binding and folding of a TM fragment,
have also been rationalized from a thermodynamic viewpoint [34].
The way the proteins are inserted in membranes in vivo, via their
interaction with the translocon, also begins to be better understood
[35,36].ining three membrane-spanning domains (MSD) and two nucleotide-binding domains
ith their corresponding tryptophan residues highlighted in black circles.
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of TM17—the last transmembrane fragment of hMRP1—in mem-
brane mimetic systems, by means of Trp ﬂuorescence and far UV
circular dichroism [37]. We chose to study this segment, because
some of its polar amino acid residues, including its single-Trp1246
residue, have been shown to be important for the function of the
protein, particularly as concerns the transport of estradiol 17-(β-D-
glucuronide), an endogenous metabolite [38,39]. Molecular model-
ing of MSD1 and MSD2 has suggested that TM17 was part of the
transmembrane transport pore, as well in the initial model of this
pore [26] as in the recent model that includes a larger number of
TM segments [27]. Our results were consistent with an interfacial
location of this fragment in the DPC and DM micelles used as
membrane mimics, as shown by both the shallower position of the
Trp in the mixed peptide-detergent micelles than in the single-Trp
model transmembrane peptides studied in the same conditions
[37,40] and by the only partial structuring of the peptide into an α-
helix. We therefore suggested that additional factors, such as
interactions with other TM, were required to maintain TM17 in a
transmembrane position.
In this work, we extended this approach to the TM fragment
preceding TM17 in hMRP1, TM16, and added to our previous
results, using new synthetic peptides for TM17 (Table 1). TM16 is
a good candidate for interaction with TM17, because these two
segments are linked together in the protein by a short loop of few
residues, located between V1219 and A1227, in the various TM
structure predictions (Scheme 1). Site-directed mutagenesis experi-
ments have also indicated that the ionizable residues of TM16,
Arg1197, Arg1202, and Glu1204, play a crucial role in protein
expression, substrate binding, and/or transport [41]. These residues
are strongly conserved in the ABCC family. TM16 also contains a
single tryptophan residue, Trp1198, located on the cytoplasmic side
of the protein, like the Trp1246 residue of TM17, and involved in
overall transport activity [42]. The intracellular loop between TM15
and TM16 also plays a key role in transport, mostly mediated by
its charged amino acids, some of which are proximal to the TM16
N-terminus (Asp1179, Lys1181, and Asp1183) [43–46]. The choice
of appropriate fragments for study is a key issue. For this study, we
synthesized a Cys1205Ser and Cys1209Ser double mutant of TM16
(mTM16), containing a single-Trp residue, W1198, close to the N-
terminus (or W4 in the peptide sequence) (Table 1). The
replacement of these Cys residues had no effect on substrate
speciﬁcity or transport activity [47]. We synthesized a TM16 Trp
variant (W19-mTM16), in which the aromatic residue Phe1213
was replaced by a tryptophan residue, to probe a part of TM16
closer to the C-terminus (i.e., to the extracellular side in the whole
protein). The conservative substitution of Trp1198 in hMRP1
allows the protein to preserve its transport activity [42]. Similarly,
a Ala1227Lys mutant of the TM17 fragment (mTM17) containingTable 1
Sequences of the four (25-amino acid) synthetic peptides and of the corresponding wild-ty
Peptide name Amino-acid sequence
TM16 A1195NRWLAVRLECVGNCIVLFAALFAV1219
mTM16b Ac-A1195NRWLAVRLESVGNSIVLFAALFAV121
W19-mTM16 Ac-A1195NRYLAVRLESVGNSIVLWAALFAV121
TM17 A1227GLVGLSVSYSLQVTTYLNWLVRMS1251
mTM17c Ac-K1227GLVGLSVSYSLQVTTYLNWLVRMS12
W10-mTM17 Ac-K1227GLVGLSVSWSLQVTTYLNYLVRMS12
The tryptophan residue used as an intrinsic ﬂuorescent probe is shown in bold characters.
a Interfacial partitioning free energy for unstructured peptide, calculated with MPEX 3
amidated peptide.
b Sequence consistent with the prediction of Kast and Gros [19], with TM16 located betw
TM16 models N1196-A1218 [41] and W1198-A1218 [118], but is slightly extended at the
residues have been replaced by two Ser residues.
c K replaces A1227 to increase peptide solubility [37].Trp1246 (or W20) [37] and the Tyr1236Trp and Trp1246Tyr
variant of mTM17 (W10-mTM17), with its Trp closer to the
extracellular side in the whole protein, were also synthesized
(Table 1).
As previously [37,40,48], detergent micelles were chosen as
membrane mimics because they allow easier solubilization of such
amphipathic peptides and that the artefacts linked to light absorption
and scattering are minimized with respect to membrane models such
as lipid vesicles. Among various suitable detergents, DM, a neutral
detergent, was speciﬁcally chosen, in particular because we devel-
oped the use of DM-brominated analogs to study Trp location in
micelles from ﬂuorescence quenching [37,40,48]. The zwitterionic
DPC was also chosen here because it generates an interfacial region
very similar to that generated by phospholipids [49,50] and favors the
structuring of amphipathic peptides (e.g., [37,48]).
After assessing peptide binding to detergent micelles, we studied
the peptide–detergent complexes in steady-state and time-resolved
Trp ﬂuorescence experiments, including quenching with acrylamide
and brominated analogs of DM. These experiments provided
information about the Trp microenvironment, its accessibility to
quenchers, its conformer equilibrium and dynamics (subnanosecond
and nanosecond time ranges). The secondary structure of TM16 in
various media was assessed by far UV circular dichroism and
compared to that obtained for TM17 [37]. Consistent with our
previous observations, both TM16 and TM17 seemed to have an
interfacial location, which we considered to be related to the
specialization of hMRP1 in the transport of polar substrates.
2. Materials and methods
2.1. Chemicals
n-Dodecyl-β-D-maltoside (DM) was obtained from Calbiochem.
Two brominated derivatives, 7,8-dibromododecylmaltoside (BrDM)
and 10,11-dibromoundecanoylmaltoside (BrUM), were synthesized
by Insavalor (Villeurbanne, France), as previously described [51,52].
DPC was obtained from Anatrace (OH, USA). Stock solutions of these
detergents were prepared in Milli-Q water at concentrations of 100 or
200 mM. N-acetyltryptophanamide (NATA) and acrylamide were
purchased from Sigma-Aldrich. We made up a stock solution of 5 M
acrylamide in water. Methanol, ethanol, DMSO (Uvasol quality), and
TFE (for synthesis) were obtained from Merck. Buffers were ﬁltered
through Millex-HA ﬁlters (0.45 μm pore size; Millipore).
2.2. Peptide synthesis
Four 25-amino acid peptides were synthesized as triﬂuoroacetate
salts by Jerini (Berlin, Germany), as shown in Table 1: (1) a peptide,
referred to as mTM16 (Mw=2757), encompassing the predictedpe TM16 and TM17 of hMRP1.
Charge ΔGua
++,− −4.07
9-Am ++,− −3.33
9-Am ++,− −3.14
+ −6.23
51-Am ++ −5.41
51-Am ++ −5.41
.0, for partition from water to bilayer, for the N-terminal-acetylated and C-terminal-
een residues 1195 and 1220. mTM16 sequence also encompasses the more restrictive
N-terminal end, providing a native environment for Trp1198. The two wild-type Cys
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residues, Cys1205 and Cys1209, were replaced by a Ser residue (the
amino acid sequence numbering corresponding to the full-length
published sequence of human MRP1 (GenBank accession no.
2828206); (2) a double mutant of this peptide (called W19-
mTM16) (Mw=2774), in which the position of the single Trp was
changed, by two conservative substitutions, of the Trp1198 and
Phe1213 residues, which were replaced by Tyr and Trp, respectively;
(3) a peptide referred to as mTM17 (Mw=2855), as in our previous
study [37], encompassing the predicted transmembrane fragment 17
of MRP1, except that Ala1 was replaced by Lys; and (4) a double
mutant of this peptide (W10-mTM17) (Mw=2856), in which the
position of the single Trp was changed, by two conservative
substitutions, of Trp1246 and Tyr1236, which were replaced by Tyr
and Trp, respectively. These peptides were acetylated at the N-
terminus and amidated at the C-terminus. mTM16 and mTM17 were
delivered at a purity of N80–90% whereasW19-TM16 andW10-TM17
were delivered at a purity of N85–90%, according to matrix-assisted
laser desorption ionization time-of-ﬂight (MALDI/TOF) mass spec-
trometry or HPLC-MS. These peptides were used as supplied.
2.3. Peptide solubilization assays and preparation of mixed
peptide–detergent micelles
Transmembrane fragments are generally difﬁcult to handle and
solvents for stock solutions must be chosen carefully to prevent
irreversible aggregation. mTM16 was not soluble in methanol, in
contrast to mTM17, but could be dissolved in TFE. TFE was also a
suitable solvent for the other peptides and was therefore used for
peptide stock solutions in all cases (at usually 1 mM peptide).
The peptide concentrations obtained from weight measurements
and absorption spectra in TFE gave values within ∼15%. Taking into
account the peptide composition (Table 1) and using molar
absorption coefﬁcients (at 280 nm) ɛ=5600 M−1 cm−1 and
1400 M−1 cm−1 for Trp and Tyr (Phe absorption at 280 nm being
negligible), respectively, the molar absorption coefﬁcients of the
peptides were estimated as ɛmax=5600 for mTM16, 7000 for W19-
TM16, and 8400M−1 cm−1 for both mTM17 andW10-mTM17, at the
maximum absorption wavelength (∼282 nm in TFE).
For ﬂuorescence measurements, the mixed peptide–detergent
micelles were generally prepared by adding an aliquot of the peptide
stock solution to 10 mM potassium phosphate buffer, pH 7.5, at 20 °C,
supplemented with 4 mM detergent (DM, DPC, or mixtures of DM
with one of its brominated analogs), with a dilution factor of at least
100 and under constant stirring. In these conditions, most of DM and
its analogs was in the micellar form, due to their low critical micellar
concentrations (cmc) (170–180 μM, 220 μM, and 320 μM for DM,
BrDM, and BrUM, respectively) [52,53]. For DPC, 2.9 mM (of 4 mM)
detergent is micellar (as the cmc of DPC=1.1 mM [50]).
2.4. Absorption measurements
Absorption spectra were recorded on an HP8453 diode array
spectrophotometer, with a thermostatically controlled sample holder
(20 °C). The sample was continuously stirred in a 1-cm path length
cuvette.
2.5. Steady-state ﬂuorescence measurements
Fluorescence data were obtained on a Spex Fluorolog spectroﬂu-
orimeter. The temperature in the cuvette was controlled with a
thermostat and the sample was continuously stirred. We used
standard quartz cuvettes (1×1 cm). Excitation spectra were corrected
for the spectrum of the lamp and both excitation and emission spectra
were corrected for ﬂuctuations in lamp intensity (usually very small,
b1%).2.6. Spectral decomposition of steady-state ﬂuorescence emission spectra
The steady-state ﬂuorescence spectra were analyzed using up to
two four-parameter log-normal functions (a skewed Gaussian
equation) of the following form [54,55]:
I mð Þ = Imexp − ln2 = ln2ρ
 
× ln2 a − mð Þ = a − mmð Þ½ 
n o
at mbað Þ
I mð Þ = 0 at mzað Þ
Here, Im= I(νm) is the maximal ﬂuorescence intensity; νm is the wave
number of the band maximum (peak); ρ=(νm− ν−)/(ν+− νm) is
the band asymmetry parameter; ν+ and ν− are the wave number
positions of left and right half-maximal amplitudes; a is the function-
limiting point: a=νm+FWHM ρ/(ρ2−1); the full width at half-
maximum FWHM=ν+− ν−.
We ﬁtted a linear combination of this analytical model to the
emission spectra by the least squares regression method (Kaleida-
Graph, Synergy Software, PA). A good ﬁt was ensured byminimization
of the squared residuals.
2.7. Fluorescence quenching by acrylamide
Fluorescence was quenched with acrylamide, as previously
described [56]. Peptide quenching was analyzed using the classical
Stern–Volmer equation (see, for reviews, [57]):
F0 = F¼ 1þKsv Q½ 
where F0 and F are the ﬂuorescence intensities in the absence and
presence of quencher, respectively, Ksv is the Stern–Volmer quenching
constant, and [Q] is the quencher concentration. Ksv is related to the
bimolecular quenching constant kq by the following formula:
Ksv = kqτ0
where τ0 is the lifetime, in the absence of quencher, of the
ﬂuorophore.
For NATA, taken as a reference, we used the nonlinear Stern–
Volmer equation:
F0 = F¼ 1þKsv Q½ ð ÞexpV Q½ 
where V can be considered as a sphere of action around the
ﬂuorophore in which the presence of a quencher molecule results in
instantaneous (static) quenching.
2.8. Time-resolved ﬂuorescence measurements
Fluorescence intensity and anisotropy decays were measured by
the time-correlated single-photon counting technique from the
polarized Ivv(t) and Ivh(t) components. They were performed as
previously for mTM17, unless otherwise stated [37]. Brieﬂy, a light-
emitting diode (PLS 295, serial number PLS-8-2-237 from Picoquant,
Berlin-Adlershof, Germany) (maximal emission at 298 nm) working
at 10 MHz was used as an excitation source and a Hamamatsu
photomultiplier (model R3235-01) was used for detection. The LED
emission, focused with a UV lens, was ﬁltered through a short-pass
Asahi Spectra UV ﬁlter ZUS300. The ﬂuorescence emission was
collected through a 306AELP Omega long-pass ﬁlter and a UG11
Schott broad-band glass ﬁlter. The instrument response function was
obtained at the excitation wavelength, with a glycogen scattering
solution. As previously described, ﬂuorescence intensity I(t) and
anisotropy decays A(t) were analyzed as sums of 150 or 100
exponential terms, respectively, by the maximum entropy method
(MEM) [58,59] according to the following equations:
I tð Þ =
X
αiexp −t=τið Þ
Fig. 1. Titration of the W19-mTM16 mutant with DPC and DM. We added 8 μM W19-
mTM16 (circles) to 10mMpotassium phosphate buffer, pH 7.5, at 20 °C. Aliquots of DPC
(closed symbols) or DM (open symbols) were then added sequentially, with
continuous stirring, at constant intervals (∼50 s). Fluorescence intensity was recorded
continuously with λex set at 280 nm. λem was set at 334 and 331 nm with DPC and DM,
respectively. Slit widths were 1.25 mm (bandwidths ∼5 nm) for both excitation and
emission. The ﬂuorescence intensities obtained after each addition of detergent were
plotted as a function of total detergent concentration. DPC and DM cmcs are indicated
as dotted lines.
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and
A tð Þ =
X
βiexp −t=θið Þ
where βi is the anisotropy and θi the rotational correlation time. In
this analysis, we assume that each lifetime τi is associated with all
rotational correlation times θi [60]. The main advantage of MEM is
that it does not impose any particular number of signiﬁcant
parameters for the decay. The Skilling–Jaynes entropy Swas subjected
to a χ2 constraint [61] to ensure that the recovered distribution was
consistent with the data.
2.9. Circular dichroism
Far UV circular dichroism spectra were recorded on a Jobin Yvon
CD6 spectrodichrograph calibrated with ammonium d-10 camphor-
sulfonate. Measurements were made at 20 °C, using a 0. 1-cm path
length quartz cuvette (Hellma) for 20 μM (or 25 μM) peptide in
10 mM potassium phosphate buffer, pH 7.5, with or without 4 mM
detergent (DPC or DM). In TFE, peptide concentration was 100 μM in a
0. 01-mm path length cuvette. Spectra were recorded in the 185 to
250-nmwavelength range, with 0.5- nmwavelength increments, a 2-
nm spectral bandwidth, and a 2- s integration time. Spectra were
averaged over four scans and corrected for background. Unsmoothed
spectra are presented.
Secondary structure was analyzed with the DICHROWEB Web
server (http://dichroweb.cryst.bbk.ac.uk/html/home.shtml) [62,63].
Two different methods for analyzing protein CD spectra (CONTIN/LL
and CDSSTR), two reference protein sets—set 3 (wavelength range:
185–240 nm, 37 proteins) and set 6 (wavelength range: 185–240 nm,
42 proteins)—and two scaling factors were tested. The CDSSTR
method with protein set 6, using the mTM16 concentration
determined by absorption, gave by far the most reliable analysis, as
shown by the NRMSD (normalized root mean square deviation;
range: 0.002–0.08) and comparison of the calculated and experimen-
tal spectra. This analysis was therefore used to evaluate mTM16
secondary structure.
3. Results
3.1. Binding of the TM16 and TM17 fragments to DM and DPC micelles
Each of the four fragments studied contained a single-Trp
residue, the ﬂuorescence of which provided information about the
local properties of the peptide and of its local environment. Peptide–
detergent interaction resulted in an increase in Trp ﬂuorescence
intensity, which was maximal for the W19-mTM16 fragment (see
below). As an example, Fig. 1 shows the titration curve of W19-
mTM16 ﬂuorescence intensity as a function of detergent concentra-
tion (intensity measured at the maximum emission wavelength
obtained in the presence of excess detergent). Signiﬁcant peptide–
detergent interaction was detected below the cmc of DPC (e.g., at
0.5 mM DPC), probably due to the interaction of detergent
monomers with monomers or oligomers of this amphiphilic peptide,
these oligomers forming rapidly in the absence of detergent
micelles. Fluorescence continued to increase above the cmc of DPC
(1.1 mM), to reach a plateau at ∼2 mM detergent, a concentration at
which no residual free peptide should be detected. Similar observa-
tions were recorded for DM, but with the binding curve shifted to
lower detergent concentrations, due to the lower cmc of DM
(∼0.18 mM), and a smaller increase in ﬂuorescence intensity. The
other peptides behaved in a similar manner, but displayed a smaller
increase in ﬂuorescence intensity (not shown). All other ﬂuores-
cence experiments were performed in the presence of excess
detergent (4 mM) and the peptide was systematically added tothe solution after the detergent, to prevent peptide oligomerization
in buffer alone.
3.2. Steady-state ﬂuorescence spectra of TM16 and TM17 fragments in
buffer, DM, and DPC
The ﬂuorescence emission spectra of W4 in mTM16 and of W19 in
the W19-mTM16 mutant, dispersed in buffer at micromolar concen-
trations from a stock solution in TFE, displayed maxima at 331–
332 nm (Fig. 2A and B). By contrast to NATA, a model for a Trp
completely accessible to the aqueous medium, which emits at
∼353 nm in the same experimental conditions, this suggests that
the Trp residues in these peptides were not fully exposed to the
aqueous solvent, probably due to the formation of oligomers.
However, when diluted to the same concentrations in an excess of
DM or DPC micelles in buffer, both peptides readily interacted with
both detergent micelles, resulting in a signiﬁcant increase in
ﬂuorescence intensity and a λmax in the 331–335 nm range (Table
2). There was a striking difference between the two peptides in the
presence of detergent micelles, with the ﬂuorescence intensity
recorded for W19-mTM16 (Fig. 1B) almost three times higher than
that recorded for mTM16 (Fig. 1A). W19-mTM16 contains one Tyr
residue in addition to its single-Trp residue (Table 1), but even
efﬁcient Tyr-Trp energy transfer could not account for such a large
difference. Thus, for the peptides in detergent, the microenvironment
or conformation of W19 must differ signiﬁcantly from that of W4 and
this difference should be evident in time-resolved ﬂuorescence
measurements. By contrast, the λmax values of W4 and W19 were
similar (within 1 nm) in all conditions.
Both peptides displayed a small but signiﬁcant λmax blue-shift
(3 nm) in the presence of DM micelles with respect to DPC micelles.
This blue-shift indicates that the Trp environment in DM micelles is
slightly less polar than in DPC. The ﬂuorescence emission spectrawere
decomposed further into elemental spectra, using log-normal Gauss-
ian distributions [54,55,64,65]. In TFE, used as the reference,
monomodal emission spectra were observed with a maximum at
∼347 nm (not shown), indicating a homogeneous environment for
Trp. By contrast, bimodal emission was observed for the fragments in
both DM and DPC micelles (Table 2): a minor short-wavelength
Fig. 2. Fluorescence emission spectra of the hMRP1 fragments in various media. (A and B) Emission spectra for 10 μMmTM16 (black lines) and W19-mTM16 (red lines) in 10 mM
phosphate buffer, pH 7.5, alone (dotted line) or supplemented with 4 mM DPC (continuous line) or DM (dashed line), at 20 °C. λex was set at 280 nm. Slit widths were 1.25 mm
(bandwidths ∼5 nm) for both excitation and emission. Spectra were recorded after a short period of equilibration (2–3 min), and the readings for background spectra (detergent in
buffer) were subtracted. The emission spectrum of NATA in the same conditions is indicated as a reference (green line). (C and D) emission spectra for mTM17 (black lines) and
W10-mTM17 (red lines), as in panel A and B.
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39% of the raw spectrum and amajor spectrum red-shifted by ∼20 nm
(maximum ∼341–345 nm). These ﬁndings are consistent with a
heterogeneous environment for the Trp residue.
Similar experiments were performed with W10-mTM17 and, for
the sake of comparison, with mTM17 prepared as for the other
fragments, from a stock solution in TFE. The emission spectra of these
peptides in buffer and detergent micelles are shown in Fig. 2C and D.
These fragments each contain a single-Trp and two-Tyr residues. Here
again, the raw spectra are blue-shifted with respect to NATA, with
λmax values ranging from 328 to 337 nm, indicating partial Trp
shielding from bulk water in all conditions. Higher ﬂuorescence
intensity values were recorded in the presence of detergent micelles.
In detergent micelles, W10-mTM17 had a slightly higher ﬂuorescenceTable 2
Fluorescence emission spectra decomposition into log-normal Gaussian curves for the TM16
Materials and methods. λmax is calculated as 104/νm and the spectrum peak height is calcu
parameter was kept constant at 1.042.
Peptide Solvent Raw spectrum Log-normal Gaussian no. 1
λmax (nm) λmax (nm) FWHM (cm−1)
mTM16 DPC 335 326 3604
W19-mTM16 DPC 334 324 3582
mTM16 DM 332 323 3652
W19-mTM16 DM 331 321 3497
mTM17 DPC 337 331 4488
W10-mTM17 DPC 335 327 4292
mTM17 DM 337 330 4787
W10-mTM17 DM 330 318 3816intensity than mTM17 and its spectrum displayed a slight blue-shift
(Table 2). As for the TM16 fragments, log-normal decomposition of
the ﬂuorescence emission spectra showed bimodal emission. We
noticed a signiﬁcant blue-shift (particularly in DM) of each W10
elemental spectrum with respect to that of W20, corresponding to a
location of W10 in DM micelles deeper than that of W20.
3.3. Quenching, by acrylamide, of the ﬂuorescence of the Trp residue in
the TM16 and TM17 fragments incorporated into DM and DPC micelles
We evaluated Trp insertion into detergent micelles, by assessing
its accessibility to the neutral water-soluble ﬂuorescent quencher
acrylamide [57]. The Stern–Volmer ﬂuorescence quenching plots
obtained for the TM16 peptides in the presence of DM or DPCand TM17 fragments in DPC or DMmicelles. The decomposition procedure is detailed in
lated as Imax/ΣImax. FWHM is the spectrum full width at half-maximum. The skewness
Log-normal Gaussian no. 2
Peak height (%) λmax (nm) FWHM (cm−1) Peak height (%)
38 345 4858 62
34 345 4935 66
39 342 5012 61
38 341 4989 62
51 348 5277 49
37 342 6285 63
44 346 5412 56
30 337 5251 70
Fig. 3. Stern–Volmer plots of the quenching by acrylamide of the ﬂuorescence of hMRP1
fragments in DPC and DM micelles. (A) We added 8 μM mTM16 (closed symbols) or
5 μM W19-mTM16 (open symbols) to 10 mM potassium phosphate buffer pH 7.5, at
20 °C, supplemented with 4 mM DPC (circles) or DM (squares). Aliquots of acrylamide
were then added sequentially, at constant intervals (100 s). Fluorescence intensity was
continuously recorded with λex set at 295 nm and λem set at 340 nm. Slit widths were
1.25 mm for excitation and 2.5 mm for emission. The ﬂuorescence intensities obtained
at each acrylamide concentration were corrected for blank values. The Stern–Volmer
plot for NATA (5 μM) in buffer (λem=354 nm in this case) is also shown, as a reference
(continuous line). A straight line was ﬁtted to the data forMRP1 fragments, whereas the
modiﬁed Stern–Volmer equation was used for NATA. (B) Similar experiment as in panel
A, but with 5 μM mTM17 (closed symbols) or W10-mTM17 (open symbols).
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and typical of a collisional (dynamic) mechanism. Similar behavior
was observed for mTM17 [37] and W10-mTM17 (Fig. 3B). TheTable 3
Parameters of the quenching by acrylamide of the ﬂuorescence of various MRP1 peptides i
Sample Medium bτN (ns)
NATA Buffer 3.0
mTM16 DPC micelles 2.97
W19-mTM16 DPC micelles 4.37
mTM16 DM micelles 2.54
W19-mTM16 DM micelles 3.29
mTM17 DPC micelles 2.92
W10-mTM17 DPC micelles 2.87
mTM17 DM micelles 2.45
W10-mTM17 DM micelles 2.44
For peptides, the amplitude-averaged lifetime values, bτN=Σαiτi, were taken from Table
kq=Ksv/bτN.apparent accessibility to acrylamide of the Trp residues in the
studied peptides incorporated into detergent micelles was signiﬁ-
cantly lower than that of NATA in buffer, taken as a reference (Fig. 3
and Ksv in Table 3). A more accurate comparison of solvent
accessibility can be made on the basis of bimolecular quenching
constants kq than based on Ksv, because the differences in bτN, the
amplitude-averaged excited state lifetime of the Trp residue in the
absence of quencher, are taken into account (kq=Ksv/bτN). kq
values ranged from 20% to ∼50% compared to that of NATA (Table
3). In both detergents, each mutant peptide was less accessible to
acrylamide than the corresponding “native” peptide. In addition, the
Trp residue of each peptide was less accessible to acrylamide in DM
micelles than in DPC micelles. Finally, consistent with previous
ﬁndings [37], the W20 residue at the C-terminus of mTM17 was
largely accessible to solvent, whereas W19 at the C-terminus of
W19-mTM16 was the more shielded from acrylamide.
3.4. Quenching, by brominated detergents, of the ﬂuorescence of the Trp
residue in the TM16 and TM17 fragments incorporated into DM and DPC
micelles
We investigated the location of Trp in the micelles in more detail,
by carrying out Trp quenching experiments with two brominated
analogs of DM: BrDM, brominated at the C7 and C8 positions of the
alkyl chain, and BrUM, brominated at the C10 and C11 positions. The
results obtained were compared with the calibration results obtained
with a set of α-helical transmembrane model peptides [40].
Quenching occurs when bromine atoms come into contact with or
are located very close to Trp. Quenching data therefore reﬂect the
accessibility of Trp to the alkyl chains.
The Trp quenching plots formTM16 andW19-mTM16 are shown in
Fig. 4. With BrDM (panel A) or BrUM (panel B) used as the quencher,
W19 was more strongly quenched than W4 (mTM16) at each
concentration of brominated detergent, implying greater contact with
the brominated detergent chains. In all cases, the residual ﬂuorescence
for completely brominated detergent (X=1) was low, below 20%,
providing direct evidence for the insertion of the peptides intomicelles.
The difference between the two Trp residues is described more
quantitatively by the parameters of the ﬁts, n and Fmin/F0, given in
Table 4. Higher values of n are associated with greater accessibility of
the Trp in the peptide to the brominated chain of the detergent. Clearly,
W19, for which up to 96% quenching was observed, with n=3.8 and
3.7, was more accessible to the brominated chains than W4.
Comparison of the Trp quenchingplots for theW10-mTM17mutant
and for mTM17 (Fig. 5) clearly indicated thatW10wasmore accessible
to the brominated chains than W20, as also shown in Table 4.
These results are consistent with those obtained with acrylamide
because, for each fragment, greater Trp accessibility to bromine is
associated with lower Trp accessibility to acrylamide.
For a more detailed interpretation, the insets show the position of
the n values obtained here with those obtained with model peptides.
The calibration curve obtainedwith BrUM (inset in Figs. 4 and 5, paneln DPC and DM micelles.
Ksv (M−1) kq (M−1 s−1) (% of reference)
17.5 5.83×109 (100%)
6.54 2.20×109 (38%)
6.98 1.60×109 (27%)
3.40 1.34×109 (23%)
3.82 1.16×109 (20%)
8.94 3.06×109 (52%)
6.26 2.18×109 (37%)
6.5 2.65×109 (45%)
3.56 1.45×109 (25%)
5. For NATA, bτN was taken from a previous study [119]. Ksv is the slope from Fig. 3.
Table 4
Parameters of the ﬂuorescence quenching curves of various MRP1 fragments in mixed
micelles of DM with BrDM or BrUM.
Fragment Mixed micelles n Fmin/F0
mTM16 DM/BrDM 2.5 14%
W19-mTM16 DM/BrDM 3.8 6%
mTM16 DM/BrUM 3.1 17%
W19-mTM16 DM/BrUM 3.7 6%
mTM17a DM/BrDM 2 22%
W10-mTM17 DM/BrDM 3.7 4%
mTM17a DM/BrUM 2.9 27%
W10-mTM17 DM/BrUM 4.0 5%
n and Fmin/F0 were obtained from the ﬁt of the quenching curves in Fig. 4.
a From [37].
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being located at the end of the detergent chain. Trp ﬂuorescence in the
various MRP1 fragments was quenched to various extents by BrUM,
but none of the n values obtained reached those obtained for the P9,
P11 and P13model peptides, for which Trp is located in the inner core
of themicelle. The location of the Trp residues of TM16 and TM17may
therefore be restricted to the polar head group region of the micelle.
3.5. Time-resolved ﬂuorescence intensity measurements for the Trp
residues in the TM16 and TM17 fragments incorporated into DM and
DPC micelles
The ﬂuorescence intensity decays of the Trp residues in all the
studied peptides, whether in buffer solution or incorporated into
detergent micelles, were multiexponential (Fig. 6A). Three excited
state lifetime populations resulted from MEM analysis in most casesFig. 4. Quenching of the ﬂuorescence of hMRP1 TM16 fragments in mixed micelles of
BrDM/DM (panel A) or BrUM/DM (panel B). (A) duplicate independent measurements
of the ﬂuorescence intensity (after 3 minutes of equilibration) of 5 μMmTM16 (closed
symbols) or W19-mTM16 (open symbols) were made in 10 mM phosphate buffer pH
7.5, supplemented with various mixtures of BrDM and DM, at a ﬁnal total detergent
concentration of 4 mM, at 20 °C. Fluorescence intensity is plotted as a function of X, the
molar fraction of brominated detergent. λex was set at 280 nm and λem at 332 and
331 nm for mTM16 and W19-mTM16, respectively (slit width=1.25 mm for both
excitation and emission). A curve was ﬁtted to the data, as described in Materials and
methods. The insets show the calibration curves of the n parameter with Trp position,
obtained with six model peptides in BrDM/DM [40]. The horizontal lines represent the
n values obtained here for the TM16 fragments. (B) Similar experiment as in panel A,
but with BrUM as the brominated detergent.(Table 5). The respective barycenter of each population for the different
peptideswas in the rangeof 0.3 to0.75ns for the shortest lifetime, 1.3 to
2.5 ns for the intermediate lifetime and 3.4 to 6.1 ns for the longest
lifetime (Table 5). The amplitude-averaged lifetime bτN for W19-
mTM16 was signiﬁcantly higher than that for mTM16 in both
detergents, consistent with the observed increase in ﬂuorescence
intensity. This effect results principally from the increase in the longest
lifetime value and its amplitude. By contrast, in bothmTM17 fragments,
bτN remains approximately constant, due to compensation between aFig. 5. Quenching of the ﬂuorescence of hMRP1 TM17 fragments in mixed micelles of
BrDM/DM (panel A) or BrUM/DM (panel B). Quenching curves for mTM17 (closed
symbols) and W10-mTM17 (open symbols) with BrDM (panel A) or BrUM (panel B) as
the brominated detergent. λem was set at 330 nm for W10-mTM17. The curves for
mTM17were obtained in a previous study [37] (with λem=335 nm), and only the points
at X=1 were checked here. Otherwise, the experiments were performed as in Fig. 4.
Fig. 6. Time-resolved ﬂuorescence of hMRP1 TM16 fragments in DPC micelles. (A)
Experimental ﬂuorescence intensity decay of mTM16 (blue trace) and W19-mTM16 (red
trace) in DPC. Instrumental response function (black trace). (B) Experimental ﬂuorescence
anisotropy decay of mTM16 in DPC. (C) Experimental ﬂuorescence anisotropy decay of
W19-mTM16 in DPC. Experimental conditions are described in Materials and methods.
Peptide concentration: 10 μM.
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increase in the contribution of the intermediate lifetime (Table 5).
3.6. Dynamics of the Trp residue in the TM16 and TM17 fragments
incorporated into DM and DPC micelles
Trp dynamics, which may also reﬂect peptide and peptide–
detergent dynamics, was monitored by evaluating time-resolved
ﬂuorescence anisotropy. The experimental anisotropy decay curves of
the Trp residues of these peptides in buffer and incorporated intodetergent micelles included a fast component, consistent with the
rapid dynamics of the indole ﬂuorophore, followed by a slower
component (Figs. 6B and C). Data analysis byMEM showed there to be
two to three time components: one or two short components with
values of 0.3 to 0.9 and 1.1 to 6 ns and amuch longer component, with
values from 12 up to 70 ns (Table 6). The shortest rotational
correlation timeprobably reﬂects the localmotion of the chromophore
around the Cα–Cβ–Cγ bonds, whereas the intermediate time
constants probably describe local peptide ﬂexibility. The longest
rotational correlation times describe the overall Brownian motion of
the entire peptide–detergent assembly and peptide aggregate in
buffer. Some are at the limit of what can be accurately measured, not
longer than ∼10 times the Trp lifetime value, i.e. ∼25 to 45 ns in our
experimental conditions. The rotational correlation times obtained in
the presence of detergent are signiﬁcantly higher than those expected
for pure detergent micelles, consistent with larger aggregation
numbers and/or more elongated shapes for some of the peptide–
detergent assemblies. However, shorter correlation times (as seen
from β1 and β2 values) also make a signiﬁcant contribution, indicating
large amplitude of motion for the Trp residues in all peptides, with
wobbling-in-cone angle values in the range of 30°–38° (Table 6).
3.7. Secondary structure
We carried out a far-UV CD study of mTM16 in various conditions
(Fig. 7A). The CD spectrum of mTM16 in TFE, used as a reference, is
indicative of a predominantly α-helical conformation, with a
characteristic high maximum at ∼192 nm and two minima at ∼208
and 220 nm. By contrast, the CD spectrum of mTM16 solubilized in
buffer was very ﬂat, indicating an absence of helical structure. In the
presence of DM or DPC micelles, signiﬁcant structural changes
occurred, making it impossible to identify a predominant structure.
Deconvolution of these spectra was required to identify the various
spectral components.
The fractions ofα-helix, β-strands, turns and unordered structures
obtained formTM16 are presented as histograms in Fig. 7B. In TFE, this
fragment was mostly α-helical (∼60% α-helix), as expected from the
shape of its CD spectrum. In buffer alone, the structure of this
fragment consisted principally of β-strands, together with unordered
structures. In both DM and DPC, mTM16 appeared to be structured
partly into a helix (up to 20% helical structure, potentially
corresponding to a short helix consisting of ﬁve of the 25 amino
acids) coexisting with signiﬁcant β-strands.
The secondary structure of mTM17 has previously been analyzed
by the same method in methanol, buffer, and in the presence of DM
and DPC micelles [37]. This fragment had a higher tendency to be
structured, with close to 80% α-helix in methanol, and up to ∼50% α-
helix in DPC, the most structuring detergent.
As for the variants, it is known for long that each amino acid has a
certain propensity to form an α helix in a protein (or peptide). In
particular, there is a correspondence between the side chain
hydrophobic surface and the helix propensity, and as a consequence,
Trp, Phe, and Tyr have very similar helix propensity values (0.58, 0.59,
and 0.72, respectively, on a scale where the propensity is 0.00 for Gly
and 0.96 for Ala) [66]. Because our mutations were only W→Y,
Y→W, or F→W, we believe that only slight structural changes might
have occurred.
4. Discussion
In the consensus hMRP1 topology (Scheme 1), the protein consists
of three membrane-spanning domains, encompassing up to 17
putative transmembrane helices (TM) and two nucleotide-binding
domains [5]. Except for MSD0, the protein is similar to other ABC
transporters, “full transporters” or homodimers of “half-transporters.”
The recent homology modeling based on the structure of the Sav1866
Table 5
Parameters of the ﬂuorescence intensity decays of the Trp residue in the peptides studied, in various media.
Peptide Medium α1 α2 α3 τ1 (ns) τ2 (ns) τ3 (ns) bτN (ns)a
mTM16 Buffer 0.40±0.01 0.40±0.01 0.20±0.01 0.41±0.08 1.51±0.09 4.03±0.06 1.60±0.07
W19-mTM16 Buffer 0.34±0.03 0.40±0.03 0.26±0.02 0.43±0.07 1.53±0.17 4.22±0.37 1.87±0.11
mTM16 DPC 0.27±0.04 0.28±0.04 0.45±0.06 0.48±0.18 1.93±0.52 5.12±0.40 2.97±0.23
W19-mTM16 DPC 0.15±0.07 0.18±0.01 0.67±0.06 0.30±0.06 1.49±0.42 6.05±0.18 4.37±0.20
mTM16 DM 0.33±0.03 0.33±0.03 0.34±0.09 0.48±0.22 2.10±0.69 4.98±0.67 2.54±0.22
W19-mTM16 DM 0.27±0.05 0.35±0.06 0.38±0.14 0.74±0.32 2.52±0.95 5.76±0.85 3.29±0.14
mTM17 Buffer 0.37±0.11 0.38±0.05 0.25±0.06 0.45±0.01 1.35±0.29 3.42±0.08 1.59±0.04
W10-mTM17 Buffer 0.48±0.07 0.35±0.05 0.17±0.02 0.40±0.04 1.26±0.12 3.62±0.34 1.38±0.25
mTM17 DPC 0.33±0.02 0.22±0.01 0.44±0.02 0.41±0.07 1.69±0.41 5.24±0.23 2.92±0.07
W10-mTM17 DPC 0.29±0.01 0.37±0.04 0.34±0.04 0.54±0.06 2.24±0.32 5.66±0.29 2.87±0.10
mTM17 DM 0.35±0.05 0.31±0.04 0.34±0.03 0.33±0.04 1.73±0.08 5.13±0.13 2.45±0.23
W10-mTM17 DM 0.34±0.01 0.44±0.01 0.22±0.02 0.55±0.03 2.33±0.11 5.45±0.12 2.44±0.04
Experimental conditions as in Fig. 6. Mean values±standard errors on a signiﬁcant number of measurements (≥2) are given.
a bτN is calculated as bτN=Σαiτi.
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hMRP1 TM helices in this sharedmembrane core [27], now suggesting
the involvement of nearly all MSD1 and MSD2 TM fragments for
constituting the transport pore. However, because of the low
sequence similarity of hMRP1 and Sav 1866, experimental structural
studies are still required.
We therefore initiated a study of the folding and topological
properties of isolated TM segments from hMRP1. TM16 and TM17 [37]
were ﬁrst chosen for study, on the basis of previous mutational and
labeling studies highlighting their importance for substrate recogni-
tion and transport by hMRP1. Each of these TM peptides contains a
single-Trp residue involved in hMRP1 function. We were therefore
able to make use of the high sensitivity of the ﬂuorescence emission of
tryptophan residues to their environment, making it possible to use
tryptophan as a natural tag for probing environmental changes.
Tryptophan ﬂuorescence emission spectra are known to be highly
sensitive to the polarity properties of the environment surrounding
the tryptophan residue [67,68], with peak emission ranging from
∼305 nm for total shielding from the solvent in azurin [69,70], to
∼350 nm for full exposure to the solvent in small water-soluble
peptides [71–73] or unfolded proteins [59,74]. Moreover, tryptophan
ﬂuorescence intensity decay is a sensitive indicator of rotamer
conformation [75–80] and of interaction with the environment,
such as solvent–exciplex formation [81–84] or dipolar relaxation
[85–90]. We therefore used a strategy combining conservative site-
speciﬁc single-Trp mutagenesis with ﬂuorescence spectroscopy and
circular dichroism spectroscopy to study the location and dynamics of
these isolated TM peptides in membrane mimics constituted by
detergent micelles. Based on our previous studies [37,40,48], DM and
DPC were selected as suitable detergents.Table 6
Parameters of the ﬂuorescence anisotropy decays of the Trp residue in the peptides studied
Peptide Medium β1 β2 β3
mTM16 Buffer — 0.027±0.008 0.122±0.01
W19-mTM16 Buffer — 0.032±0.003 0.091±0.01
mTM16 DPC — 0.040±0.009 0.117±0.01
W19-mTM16 DPC 0.063±0.043 0.060±0.014 0.081±0.01
mTM16 DM — 0.033±0.011 0.132±0.01
W19-mTM16 DM 0.021±0.004 0.035±0.008 0.091±0.00
mTM17 Buffer — 0.063±0.003 0.063±0.00
W10-mTM17 Buffer — 0.009±0.007 0.104±0.00
mTM17 DPC 0.051±0.010 0.073±0.015 0.065±0.01
W10- mTM17 DPC 0.021±0.008 0.054±0.030 0.083±0.03
mTM17 DM 0.026±0.004 0.061±0.019 0.081±0.02
W10-mTM17 DM — 0.023±0.008 0.115±0.01
The anisotropy βi is the area and the rotational correlation time θi is the bary center of peak i
At=0=Σβi. The semiangle ωmax of the wobbling-in-cone subnanosecond motion was calcula
(Σβns/A0)1/2)1/2−1], where A0 is Trp anisotropy in the absence of depolarization and βns is t
picosecondsdiode laser PLS295wascalculated fromthewavelengthconvolutionof thenanoLED
errors on a signiﬁcant number of measurements (≥2) are given.Before characterizing the peptide–micelle complexes, we checked
that the peptides bound to DM and DPC micelles in the usual
experimental conditions for ﬂuorescence and CD studies (μM range
for peptide concentration). Peptide binding was always complete at a
detergent concentration of 4 mM, as clearly exempliﬁed for W19-
mTM16. Further evidence for peptide–detergent interaction was
provided by the high level of quenching of Trp ﬂuorescence by 4 mM
brominated analogs of DM (BrDM and BrUM). Quenching levels
reached ∼75% [37] to 95% (Figs. 4 and 5, Table 4), indicating Trp–
bromine atom contact or very close proximity.
Peptide binding was expected, given the hydrophobic character of
both TM16 and TM17, as quantiﬁed by their interfacial partitioning
free energy for unfolded peptide (ΔGu), which depends solely on
amino acid composition [91]. With a ΔGu of−4.1 and−6.2 kcal/mol
(Table 1), native TM16 and, to a lesser extent TM17, are, however, less
hydrophobic than many of the other predicted TM segments of
hMRP1 and, for example, than TM1 and TM2 (ΔGu=−14.7 and
−9.2 kcal/mol, respectively). The small sequence changes introduced
(C→S, Trp mutation) also rendered our synthetic peptides slightly
less hydrophobic than their native counterparts (Table 1).
We next characterized the emission spectra of the peptide–
detergent complexes. Our previously studied transmembrane model
peptides, which had single–Trp residues in various positions in the
polypeptide sequence, had ﬂuorescence emission maxima from 327–
330 nm to 313–314 nm for interfacial and the deeply embedded Trp,
respectively, in DM or in DPCmicelles [37,40,52]. For tryptophan octyl
ester, the ﬂuorescent moiety of which is probably located close to the
polar head group region, emission peaked at 335 nm in both DM and
DPC micelles [52,56]. For the various TM16 fragments, incorporated
into DPC or in DM, W4 and W19 mutant displayed mean maximum, in various media.
θ1 (ns) θ2 (ns) θ3 (ns) ωmax (°) At=0
2 — 3±1 ∞ 0.149±0.004
1 — 2.3±0.9 ∞ 0.123±0.011
3 — 2.7±0.7 20±2 31 0.157±0.010
4 0.3±0.1 2.7±0.7 49±5 35 0.204±0.050
0 — 3.1±1.4 51±16 30 0.165±0.014
6 0.9±0.4 3.4±0.6 70±19 38 0.147±0.007
6 — 1.1±0.1 ∞ 0.126±0.005
1 — 1.2±0.6 ∞ 0.113±0.007
2 0.30±0.01 3.8±0.5 17±4 35 0.189±0.007
6 0.7±0.05 3.0±1.6 12±3 35 0.158±0.005
0 0.55±0.17 6.1±1.0 50±27 34 0.168±0.004
0 — 2.2±0.5 21±9 35 0.137±0.010
of the rotational correlation time distribution. At=0 is the anisotropy at time zero, with
ted from: Σβns/A0=[1/2cosωmax(1+cosωmax)]2, which gives: ωmax=arccos1/2[(1+8
he anisotropies of the nanosecond components. A value of 0.251 for excitation with the
optical power emissionwith the intrinsicanisotropyofNATA [37].Meanvalues±standard
Fig. 7. Far UV CD results for mTM16 in various media. (A) CD spectra in millidegrees, for
20 μMmTM16 in a cuvette with a 1-mm path length. The mediumwas TFE (continuous
line), buffer alone (dotted line), or contained 4 mM DPC (long-dashed line) or DM
(dashed-dotted line). (B) Histograms for the various structural elements.
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slightly longer than those displayed by the Trp residue of the
transmembrane model peptides (P3, P5, and P7), that were closer to
the water/micelle interface in the same detergents [37,40]. TheW4 or
W19 residue was therefore located in the polar head group region of
the detergent micelles rather than in their hydrophobic core.
However, this location may be considered an average location
because, as observed for the transmembrane model peptides,
ﬂuorescence emission spectrawere polymodal and could be described
as the sum of two elemental spectra: one with a maximum at ∼321–
326 nm and the other with a maximum at ∼341–345 nm [37,40].
Despite small λmax differences, the ﬂuorescence emission spectra of
W20 in mTM17 andW10 inW10-mTM17 were also consistent with a
similar location.
According to Burstein's classiﬁcation of Trp in proteins [92,93], a
ﬂuorescence emission maximum at ∼325 nm corresponds to a Trp
residue capable of hydrogen bonding to a water molecule (or another
partner), whereas a ﬂuorescence emission maximum at ∼340 nm
corresponds to a Trp residue exposed to a slowly relaxing polar
solvent. Fluorescence spectrum decomposition therefore suggests
that the Trp residue may ﬂuctuate between a shallow location within
micelles in which a few water molecules may hydrogen bond to the
indole ring (probably the inner interface between the acyl chain and
the polar head groups) and a location at the surface, where slowly
relaxing water molecules are present (probably the interface between
water and the polar head groups). Similar features were observed for
the W19 residue of the W19-mTM16 mutant, with the exception of a
slight shift in the ﬂuorescence emission spectrum towards shorter
wavelengths, indicating a slightly deeper insertion. Similarly, W10 inthe mutated mTM17 peptide seemed to be located deeper in the
micelle than the W20 residue in mTM17.
The differences in Trp location were investigated further, with
water-soluble (acrylamide) and lipophilic (brominated analogs of
DM) quenchers. The various Trp residues were all signiﬁcantly
shielded from acrylamide, by at least 50%, whereas all were quenched
by brominated detergents to levels of up to 96%. As previously
reported [37], the sum of the ﬂuorescence intensities quenched by
acrylamide in the presence of DM and by a brominated detergent
(BrDM or BrUM) may exceed 100%, indicating that both bromines of
the acyl chains and acrylamide may be present in themicelle region in
which Trp is located. Consistent results were obtained for all the
parameters related to Trp location: λmax values, kq for acrylamide
accessibility, n and Fmin/F0 for brominated detergent accessibility.
These results suggest that the peptides are inserted into the polar
head group region of the micelles (DPC and DM) in an oblique
orientation, as the Trp residues of the mutated peptides were
embedded slightly deeper in the micelles than the corresponding
native Trp residues (lower λmax and lower kq for DM and DPC and
lower Fmin/F0 and higher n in the case of DM micelles). The more
surface-exposed regions of TM16 and TM17, respectively, probed by
the native Trp W4 and W20 residues, respectively (i.e., W1198 and
W1246 if numbered as in hMRP1), correspond to the cytoplasmic side
of the plasma membrane. Our results suggest that W1246 is the most
exposed Trp residue, whereas the non-native W19 (corresponding to
F1213 in the whole protein) is located deeper in the micelle. One can
argue that Trp mutations may introduce artefacts in peptide position
because Trp shows a preference for membrane interfaces [94]. Our
variants were chosen to minimize this effect. For TM17, the Trp
variant results from the two point mutations: Y1236W and W1246Y,
so that the overall effect onΔGu (interfacial partitioning free energy of
the peptide) is null. Moreover, since W and Y have a very similar
distribution pattern in membranes [95], our results can be considered
as quite reliable. For TM16, the variant results from the following two
point mutations:W1198Y and F1113W. The variation in overallΔGu is
not null but small (0.19 kcal/mol, as can be seen from Table 1). In this
case, since F is found equally distributed throughout the transmem-
brane region [95], there is a slight change in the distribution tendency.
However, a single Wmay not be sufﬁcient to strongly modify peptide
position: in this regard, in the study of Trp anchored model peptides,
two consecutive Trp are put at a model peptide end to study this
property (e.g., Killian et al. [96,97]). Time-resolved ﬂuorescence
analyses were carried out to gain more insight into the local
conformation and dynamics of the peptide regions labeled by W4
and W19 (i.e., W1198 and W1213, respectively). In this study, MEM
analysis showed that the ﬂuorescence intensity decays of the Trp
residues in the various peptides were mostly accounted for by three
excited-state lifetime populations in the nanosecond time range.
These lifetime values were in the same range as those characterizing
the Cα–Cβ bond Trp χ1 rotamers measured in conformationally
constrained peptides [98,99]. The data were interpreted in the
framework of the rotamer model [75,76], in which the lifetimes of
Trp Cα–Cβ rotamers depend on their sensitivity to peptide bond
quenching by electron (or proton) transfer mechanisms as a function
of their geometry and environment [77,79,100–104]. The relative
proportions of the rotamers were assumed to be governed by the
structural constraints imposed by the main peptide chain [105,106].
Using TFE as a helix promoter, we showed that the amplitude of the
longest lifetime component in single-Trp-containing peptides in
solution was clearly correlated with α-helix formation [107]. The
constraints imposed by the membrane or micellar environments may
also affect the rotamer distribution, as suggested in our previous
studies of TM model peptides in DM and DPC micelles [37,40]. Based
on these considerations, the major rotamer associated with the
longest lifetime observed for W19 may indicate that the C-terminal
amino acids of the mTM16 peptide are folded as a helix. According to
412 B. de Foresta et al. / Biochimica et Biophysica Acta 1798 (2010) 401–414our CD experiments, the mTM16 peptide may intrinsically fold
principally as an α-helix in organic solvents such as TFE (∼60%), but
it folds principally as a β-strand in the presence of detergent micelles,
with only a small proportion ofα-helix. Itsα-helix propensity is lower
than that previously observed for mTM17. mTM16 does not behave as
a spontaneous stable α-helical segment in membrane mimics, as
would be expected for a classical transmembrane fragment. It may
form a hairpin structure at the surface of the micelles or may self-
associate on the micelle, despite the presence of an excess of
detergent micelles over peptide (concentration). The self-association
of mTM16may be driven in part by ionic interactions. The N-terminus
of mTM16 bears both positive (R) and negative (E) charges,
potentially leading to a head-to-tail arrangement for the isolated
peptide. Self-association would be consistent with the rotational
correlation time values, which were longer than expected for
detergent–peptide complexes. The presence of an interfacial peptide
may also change the aggregation number of the micelle.
If these fragments do not spontaneously form transmembrane
segments, this insertionmay be driven by TM-TM interactions. Searches
of the TM16 and TM17 sequences for known membrane helix–helix
dimerization motifs, such as GxxxG [108,109], motifs including polar
residues (QxxS, SxxSSxxT, serine zipper [110]) or others (e.g., leucine
zipper [111] (and for review, see [112,113]; and [114], and references
therein), showedno such sequences to bepresent,with the exception of
the AxxxA (A-ALF-A) motif at the C-terminus of TM16. No
corresponding sequence was found at the N-terminus of TM17, but
such a sequence was identiﬁed at the N-terminus of TM15 (A-TPI-A).
The two N-termini may face the C-terminus of TM16 in the membrane
part of hMRP1. A recognized stabilization motif involving aromatic
residues, aromatic-xx-aromatic (aromatic=Wor Y) [115], is present in
the C-terminus of TM17 (Y-LN-W) and may interact with a
corresponding sequence when the transport pore is closed on the
cytoplasmic face and open towards the extracellular space. In the
opposite conformation (pore open towards the cytoplasm), the
aromatic residues may interact with polar and/or cyclic substrates.
TM helix–helix associationmay also be driven by interactions involving
only two residues, via aromatic or cation–π interactions [116]. Such
TM–TM associations may increase the helical content of each peptide
[114], making it higher enough for the formation of a transmembrane
helix.
5. Conclusion
We provide here a detailed characterization of the interaction of
hMRP1 TM16withmembranemimics and extended our previouswork
on TM17 [37]. We used Trp as an intrinsic ﬂuorescent probe. For each
TM, we used the single-Trp residue present in the wild-type peptide
(W1198 in TM16 and W1246 in TM17) and a Trp variant (W replacing
F1213 and Y1236, respectively). Both TM16 and TM17 are involved in
substrate recognition and transport by hMRP1 [38,39,41,42], and these
two fragments are among the least hydrophobic of the predicted TM
fragments of this transporter. On the basis of spectral and Trp
ﬂuorescence quenching parameters, two loci separated by 15 and 10
amino acid residues in TM16 (W4–W19) and TM17 (W10–W20),
respectively, were shown to be located in the hydrophilic region of the
micelle, in slightly different microenvironments. At this interface, TM16
folds principally into β-sheets, whereas TM17 is more helical [37].
hMRP1 is known to transport polar substrates, whereas PgP/ABCB1
speciﬁcally transports hydrophobic substrates. Consistent with this
ﬁnding, the topological polar surface area of various molecules was
recently shown to be correlated with the probability of transport by
hMRP1 [117]. The experimentally demonstrated amphipathic character
of both fragments in membrane models is consistent with the creation
by these fragments of a hydrophilic environment in the membrane, at
least on the cytosolic leaﬂet. However, the ﬁnal TM16 and TM17
structureswithin hMRP1 are likely to differ from that observed here andare probablymodulatedbyTM–TMinteractions. Further studies of these
interactions are therefore one of the avenues to be explored in future
analyses of the structure of this protein.
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